FFN
MRNA icon

Focus Financial Network’s Moderna MRNA Stock Holding History

Focus Financial Network’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,523
Closed -$302K – 692
2024
Q3 		$302K Sell
4,523
-819
-15% -$75.2K 0.01% 543
2024
Q2 		$663K Buy
5,342
+8
+0.1% +$1.01K 0.03% 338
2024
Q1 		$544K Sell
5,334
-663
-11% -$66.8K 0.03% 363
2023
Q4 		$596K Sell
5,997
-536
-8% -$45.1K 0.02% 416
2023
Q3 		$675K Sell
6,533
-742
-10% -$82.8K 0.04% 296
2023
Q2 		$884K Sell
7,275
-500
-6% -$66.7K 0.05% 258
2023
Q1 		$1.19M Sell
7,775
-44
-0.6% -$7.26K 0.07% 205
2022
Q4 		$1.4M Sell
7,819
-1,159
-13% -$190K 0.11% 152
2022
Q3 		$1.06M Sell
8,978
-436
-5% -$66.2K 0.09% 170
2022
Q2 		$1.34M Sell
9,414
-869
-8% -$124K 0.11% 152
2022
Q1 		$1.77M Buy
+10,283
New +$1.73M 0.12% 140
2021
Q1 		– Sell
-15,309
Closed -$1.6M – 473
2020
Q4 		$1.6M Sell
15,309
-10,234
-40% -$1.04M 0.14% 136
2020
Q3 		$1.81M Buy
+25,543
New +$1.78M 0.17% 124

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Focus Financial Network's MRNA Position: Q4 2024 in Review

Focus Financial Network sold out of Moderna (MRNA) in Q4 2024, closing a stake of 4,523 shares — an estimated $302K sold.

Focus Financial Network first reported a position in MRNA in Q3 2020 and held it in 13 quarters. The position peaked at $1.81M in Q3 2020. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Focus Financial Network reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Focus Financial Network sold 4,523 Moderna shares in Q4 2024, an estimated $302K.
  • Focus Financial Network first reported a position in Moderna in Q3 2020 and held it in 13 quarters.
  • Focus Financial Network's Moderna position peaked at $1.81M in Q3 2020.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Focus Financial Network's 13F filing for Q4 2024, filed 29 Jan 2025.